UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Life Science

A High impact Open-Source tool for Digital Pathology Quality Control

Ahead of his presentation at the 6th Digital Pathology and AI Congress: Europe, we spoke to Andrew Janowczyk about his work creating scalable data analysis techniques to facilitate cancer research through the development of open-source Digital Pathology tools.

Read More

The future of Pharma: harnessing AI to decentralise data

 

As Chief Data Officer for the OSTHUS Group, Eric Little co-founded LeapAnalysis, a new approach to AI, data integration and analytics. 

 

LeapAnalysis is the first fully federated and virtualised search and analytics engine that runs on semantic metadata. It allows users to combine semantic models (ontologies) with machine learning algorithms to provide customers with unparalleled flexibility in utilizing their data.

Read More

Providing Pathology Solutions to Deprived Areas Around the World

Most students and clinicians learn microbiology with the proper equipment: microscopes. However, in deprived countries front-line health facilities have to refer patients elsewhere because they do not have a microscope to enable diagnosis. Research is inhibited because of lack of equipment, students never get the opportunity to use real microscopes during their studies, and participation in science and particularly microbiology is very low.

Read More

Understanding the Role of the Gut Microbiome in NAFLD

NAFLD is the primary contributor to chronic liver disease worldwide with incident rates of 20-30% in western countries and 5-18% in Asia. The discovery of early stage biomarkers for patients with the reversible form of the disease is therefore a research priority. Recent work has shown perturbation of the microbiome and specific microbiome-associated metabolites contribute to the phenotype of NAFLD.

Read More

Presentation slides from the 5th Digital Pathology & AI Congress: USA

Following the 5th Digital Pathology & AI Congress: USA, we have made the following presentation slides available from Iman Hajirasouliha, Kim Solez and Mrinal Mandal.

Read More

A recap of the Microbiome & Probiotics Series: Europe

The Microbiome & Probiotics Series: Europe is one of the highlights of our calendar year. Kristin Neumann, author & founder of MyMicrobiome was one of our speakers on the cosmeceuticals track and was kind enough to write the following recap of the event, for people who weren’t able to attend this year. You can read the original article here.

Read More

The benefits of network-driven drug discovery

e-Therapeutics, an Oxford-based company, is using its network-driven drug discovery (NDD) technology to embrace the inherent complexity of biology, providing a novel and productive method for the discovery of new medicines.

Jonny Wray is the head of Discovery Informatics at e-Therapeutics. Trained as a computational neuroscientist, he is responsible for building the NDD technology. We spoke to him ahead of his presentation at the Global Pharma R&D Informatics & AI Congress.

Read More

Controlling the fate of cancer cells with SF3B1 modulators

Andrew Cook has worked in the pharmaceutical industry for over 20 years. Throughout his career, he has endeavoured to do things differently, a little out of the ordinary, leading him to his work at H3 Biomedicine on splice modulators. “Part of the reason it attracted me” he says, “is it’s so different. It’s a natural product-based drug discovery effort, and I had never done that before”.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive